← Eichor
Study identifier: NCT06803030 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms

Condition: Ureteral Stent-Related Symptom  ·  Sponsor: Bir Hospital

PhasePhase 3
Planned participants189
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

A comparative study on the efficacy of Tamsulosin, Solifenacin and Mirabegron in alleviating ureteral stent-related symptoms: a randomized controlled trial.

This description comes directly from the study's public registry record.

Talk to the study team

Baikuntha Adhikari, MCh  ·  +977 9849896780  ·  baikadhe@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

NAMS, Bir HospitalKathmandu, Bagmati, NepalRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06803030